MARCO and breast carcinoma: Notably, MARCO, a key protein within a subset of macrophages that are involved in phagocytosis, inflammation, and others [51], has been implicated as a new immune target for anti-TAM treatment for treating various solid tumors, including non-small-cell lung carcinoma, melanoma, and breast cancer [52].